← Back to Search

Ketone Supplement

Ketone Monoester for Cystic Fibrosis

N/A

Waitlist Available

Led By Eric P Plaisance, PhD

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 days

Awards & highlights

Study Summary

This trial will study the effects of a new ketone supplement on people with cystic fibrosis who are experiencing an acute exacerbation of their symptoms and are in the hospital.

Eligible Conditions

Cystic Fibrosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Inflammatory markers

Pulmonary Function Testing

Secondary outcome measures

Assessment of quality of life, respiratory symptoms, and patient outlook

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Ketone MonoesterExperimental Treatment1 Intervention

The ketone used is from KetoneAid and is commercially available as KE4 and will be consumed at 30 mL twice daily (15 g / dose)

Group II: PlaceboPlacebo Group1 Intervention

A placebo is being manufactured by KetoneAid to match the taste and other characteristics of the ketone supplement for blinding purposes

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ketone Monoester

2021

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,581 Previous Clinical Trials

2,278,014 Total Patients Enrolled

22 Trials studying Cystic Fibrosis

41,074 Patients Enrolled for Cystic Fibrosis

Eric P Plaisance, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there openings in this trial that are available to participants?

"Affirmative. The details on clinicaltrials.gov verify that this trial is currently enlisting participants, having initially been posted on November 1st 2021 and lastly updated on the 7th of November 2022. A total of 25 people are required from one site for enrollment in the study."

Answered by AI

How many participants is this research endeavor currently recruiting?

"Affirmative. According to the clinicaltrials.gov registry, this research is actively seeking volunteers that meet certain criteria, which was initially posted on November 1st 2021 and last updated on November 7th 2022. 25 individuals will be recruited from one medical facility for the study's duration."

Answered by AI

Does this clinical research consider elderly participants?

"This medical study is seeking participants who are 18 years and above, but whose age does not exceed 89."

Answered by AI

Who best meets the qualifications for participation in this medical experiment?

"The criteria for entrance into this medical experiment is cystic fibrosis and age between 18 to 89 years old. 25 prospective participants need to be located."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ketone Supplementation in Cystic Fibrosis

Eric P. Plaisance 2021. "Ketone Supplementation in Cystic Fibrosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04938726.